ARTEMISMEDNSEArtemis Medicare Services LimitedHighPositive
Announced Fri, 8 May · 19:10 IST

Artemis Medicare Services Limited has informed the Exchange regarding a press release dated May 08, 2026, titled "Artemis Consolidated Revenue from Operations up 16.4% in Q4 FY26 (YoY); EBITDA up 23.1%; Net Profit up 32.1%".

Pat Growth 25pctEbitda Margin ExpansionRevenue Growth 20pctResults View source PDF

ARTEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.5%1-day move
₹266.00
prior close
₹272.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.3+2.7+3.3+3.8+1.5+3.8+4.2+5.4+2.3+5.3+2.3-4.5+4.7
Up moveDown movePending
AI summary

Artemis Medicare Services reported robust Q4 FY26 consolidated results with revenue from operations at Rs 27,923 Lacs, up 16.4% YoY. EBITDA grew 23.1% to Rs 5,938 Lacs while PAT surged 32.1% to Rs 3,028 Lacs. For the full year FY26, revenue reached Rs 1,08,124 Lacs (up 15.4%) and PAT stood at Rs 10,372 Lacs (up 26.2%). The flagship Gurugram hospital drove performance with ARPOB at Rs 84,571, 64.6% bed utilisation, and overseas patient revenue contributing 30.8% to net revenue. The company is expanding with a new Raipur facility.

Likely market impact

Strong quarterly and annual growth with margin expansion indicates healthy operational performance. The 32% PAT growth in Q4 and 26% full-year PAT growth are particularly positive signals for shareholders. Growing international patient revenue and the upcoming Raipur expansion provide future growth visibility.